LeMaitre Vascular EBIT Margin 2010-2024 | LMAT
Current and historical EBIT (Earnings Before Interest & Taxes) margin for LeMaitre Vascular (LMAT) over the last 10 years. The current EBIT profit margin for LeMaitre Vascular as of December 31, 2024 is .
| LeMaitre Vascular EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2024-12-31 | $0.22B | $0.05B | 23.64% |
| 2024-09-30 | $0.21B | $0.05B | 23.00% |
| 2024-06-30 | $0.21B | $0.05B | 21.95% |
| 2024-03-31 | $0.20B | $0.04B | 20.10% |
| 2023-12-31 | $0.19B | $0.04B | 18.65% |
| 2023-09-30 | $0.19B | $0.03B | 17.84% |
| 2023-06-30 | $0.18B | $0.03B | 16.95% |
| 2023-03-31 | $0.17B | $0.03B | 15.98% |
| 2022-12-31 | $0.16B | $0.03B | 16.67% |
| 2022-09-30 | $0.16B | $0.03B | 17.39% |
| 2022-06-30 | $0.16B | $0.03B | 19.38% |
| 2022-03-31 | $0.16B | $0.04B | 22.64% |
| 2021-12-31 | $0.16B | $0.04B | 23.23% |
| 2021-09-30 | $0.15B | $0.04B | 24.84% |
| 2021-06-30 | $0.15B | $0.04B | 25.83% |
| 2021-03-31 | $0.14B | $0.03B | 24.44% |
| 2020-12-31 | $0.13B | $0.03B | 22.31% |
| 2020-09-30 | $0.12B | $0.02B | 19.67% |
| 2020-06-30 | $0.12B | $0.02B | 17.39% |
| 2020-03-31 | $0.12B | $0.02B | 17.65% |
| 2019-12-31 | $0.12B | $0.02B | 18.10% |
| 2019-09-30 | $0.11B | $0.02B | 20.18% |
| 2019-06-30 | $0.11B | $0.02B | 20.18% |
| 2019-03-31 | $0.11B | $0.03B | 26.17% |
| 2018-12-31 | $0.11B | $0.03B | 27.62% |
| 2018-09-30 | $0.10B | $0.03B | 27.18% |
| 2018-06-30 | $0.10B | $0.03B | 26.92% |
| 2018-03-31 | $0.10B | $0.02B | 21.36% |
| 2017-12-31 | $0.10B | $0.02B | 20.79% |
| 2017-09-30 | $0.10B | $0.02B | 19.39% |
| 2017-06-30 | $0.10B | $0.02B | 19.79% |
| 2017-03-31 | $0.09B | $0.02B | 18.48% |
| 2016-12-31 | $0.09B | $0.02B | 18.18% |
| 2016-09-30 | $0.09B | $0.02B | 17.65% |
| 2016-06-30 | $0.08B | $0.01B | 16.05% |
| 2016-03-31 | $0.08B | $0.01B | 15.19% |
| 2015-12-31 | $0.08B | $0.01B | 14.10% |
| 2015-09-30 | $0.08B | $0.01B | 14.29% |
| 2015-06-30 | $0.08B | $0.01B | 13.16% |
| 2015-03-31 | $0.07B | $0.01B | 12.16% |
| 2014-12-31 | $0.07B | $0.01B | 9.72% |
| 2014-09-30 | $0.07B | $0.01B | 7.04% |
| 2014-06-30 | $0.07B | $0.00B | 5.88% |
| 2014-03-31 | $0.07B | $0.00B | 4.55% |
| 2013-12-31 | $0.06B | $0.00B | 6.25% |
| 2013-09-30 | $0.06B | $0.00B | 6.56% |
| 2013-06-30 | $0.06B | $0.00B | 6.67% |
| 2013-03-31 | $0.06B | $0.00B | 6.90% |
| 2012-12-31 | $0.06B | $0.00B | 7.02% |
| 2012-09-30 | $0.06B | $0.00B | 7.27% |
| 2012-06-30 | $0.06B | $0.01B | 8.93% |
| 2012-03-31 | $0.06B | $0.01B | 8.77% |
| 2011-12-31 | $0.06B | $0.00B | 6.90% |
| 2011-09-30 | $0.06B | $0.00B | 3.39% |
| 2011-06-30 | $0.06B | $0.00B | 3.45% |
| 2011-03-31 | $0.06B | $0.00B | 5.26% |
| 2010-12-31 | $0.06B | $0.00B | 7.14% |
| 2010-09-30 | $0.06B | $0.01B | 10.71% |
| 2010-06-30 | $0.06B | $0.01B | 9.09% |
| 2010-03-31 | $0.05B | $0.00B | 7.41% |
| 2009-12-31 | $0.05B | $0.00B | 1.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.893B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| Stryker (SYK) | United States | $142.084B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Medtronic (MDT) | Ireland | $115.249B | 16.83 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| ResMed (RMD) | United States | $32.876B | 25.32 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Insulet (PODD) | United States | $18.442B | 78.86 |
| Baxter (BAX) | United States | $17.557B | 12.63 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 12.18 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |